Premium
Does measurement of ankle‐brachial index contribute to prediction of adverse health outcomes in older C hinese people?
Author(s) -
Woo J.,
Leung J.
Publication year - 2013
Publication title -
internal medicine journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 1444-0903
DOI - 10.1111/imj.12101
Subject(s) - medicine , stroke (engine) , myocardial infarction , blood pressure , hazard ratio , comorbidity , diabetes mellitus , adverse effect , physical therapy , disease , cardiology , emergency medicine , confidence interval , mechanical engineering , engineering , endocrinology
Background/Aims This study examined whether ankle‐brachial index ( ABI ) is predictive of all‐cause mortality, cardiovascular mortality, hospital admission for stroke, ischaemic heart disease or myocardial infarction among older people aged 65 years and above, and whether the inclusion of ABI in prediction models adds any incremental value to traditional cardiovascular risk factors. Methods Four thousand men and women living in the community aged 65 years and over were recruited. ABI was measured, and information regarding comorbidity, smoking habit, physical activity and physical limitation was obtained at baseline. Hospital admissions for stroke and ischaemic heart disease/myocardial infarction were documented after a mean period of 6.0 years and mortality after a mean of 9.1 years. Results ABI <0.9 alone was predictive of all outcomes with the exception of hospital admission for stroke. Inclusion of ABI in a model that includes other ‘traditional’ cardiovascular risk factors such as age; physical activity scale of the elderly; history of hypertension and other cardiovascular diseases, diabetes and smoking; and systolic blood pressure >140/90 reduced the hazard ratios but did not alter the overall results. Comparison of prediction models with and without ABI showed little difference. When different values of ABI were examined for all outcomes, values between 0.9 and 1.0 had high specificity but low sensitivity. Conclusion ABI measurement (<0.9) predicted adverse outcomes with high specificity but low sensitivity. However, it added little incremental value to prediction of adverse outcomes using traditional cardiovascular risk factors.